Cancer organizations issue recommendations to increase clinical trial diversity

ASCO and the Association of Community Cancer Centers have jointly developed recommendations for improving equity, diversity and inclusion in cancer clinical trials.
The recommendations, published in Journal of Clinical Oncology, include actions the cancer clinical trial community can take to increase participation of underrepresented individuals.
“The lack of diversity in clinical trials is a persistent challenge, caused by a variety of factors,” Lori J. Pierce, MD, FASTRO, FASCO, vice president for academic and family affairs and professor of radiation oncology at University of

ASCO and the Association of Community Cancer Centers have jointly developed recommendations for improving equity, diversity and inclusion in cancer clinical trials.
The recommendations, published in Journal of Clinical Oncology, include actions the cancer clinical trial community can take to increase participation of underrepresented individuals.
“The lack of diversity in clinical trials is a persistent challenge, caused by a variety of factors,” Lori J. Pierce, MD, FASTRO, FASCO, vice president for academic and family affairs and professor of radiation oncology at University of